Exploring the relation between stem cells and tumor growth

July 16, 2012
Exploring the relation between stem cells and tumor growth
Credit: Thinkstock

An EU research project has shed light on the tumor-growth role of a key-signalling pathway in mammary gland stem cells.

Tumor stem cells (TSCs) identified in several tumour tissues are functionally similar to mature stem cells, and are capable of creating new tumours. TSCs are thought to originate from either transformed or .

The hedgehog (Hh) signalling pathway gives stem cells the required information to differentiate. Different kinds of cells have different concentrations of Hedgehog proteins. Malfunction of the pathway can result in diseases like cancer.

The aim of the EU-funded Mammahoglgr project was to further investigate the Hh signalling pathway supporting tumour-growth role in gland stem/progenitor and .

In the framework of this project, unique and innovative tools were established. A mouse model with conditionally regulated Hh-pathway activation was created in the mammary gland. This model was used for monitoring the dynamic changes in the stem/progenitor .

Furthermore, an innovative tumor mouse line was developed, in which the Hh-pathway could be activated and deactivated. This cell line promises to shed light on the early stages of tumour development and identify the cancer-initiating cells.

The results showed a significant increase in tumor formation and growth rate upon Hh-pathway activation. Additionally, stem cell marker Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) was over-expressed in and induced by Hh pathway activation tumours, suggesting that these tumors are less differentiated. Therefore, the system of induced tumours developed within Mammahoglgr project represents a relevant model to investigate the role of the Hh-pathway in .

The confirmation of the role of an activated Hh-pathway in the development of breast cancer and the tools developed will guide the therapeutic strategies to new, specifically targeted drugs.

Explore further: RANK protein promotes the initiation, progression and metastasis of human breast cancer

Related Stories

RANK protein promotes the initiation, progression and metastasis of human breast cancer

April 24, 2012
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial ...

Regulation of telomerase in stem cells and cancer cells

June 27, 2012
Scientists at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have gained important insights for stem cell research which are also applicable to human tumours and could lead to the development of new ...

Key growth factor identified in T cell leukemia

August 1, 2011
Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.

Recommended for you

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Study reveals complex biology, gender differences, in kidney cancer

October 13, 2017
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

Cholesterol byproduct hijacks immune cells, lets breast cancer spread

October 12, 2017
High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link. A new study by University of Illinois researchers found ...

New drug hope for rare bone cancer patients

October 12, 2017
Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal ...

Scientists pinpoint surprising origin of melanoma

October 12, 2017
Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular origin of cutaneous melanoma, the deadliest form of skin cancer. The team was surprised to observe that these very aggressive ...

Team finds a potentially better way to treat liver cancer

October 12, 2017
A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.